Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Purpose We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarcinoma. Patients and Methods Chemotherapy consisted of gemcitabine (750 mg/m2) and...

Full description

Saved in:

Bibliographic Details
Main Author:	Varadhachary, Gauri (author)
Other Authors:	Wolff, Robert (author), Crane, Christopher (author), Sun, Charlotte (author), Lee, Jeffrey (author), Pisters, Peter (author), Vauthey, Jean-Nicolas (author), Abdalla, Eddie (author), Wang, Huamin (author), Staerkel, Gregg (author), Ross, William (author), Tamm, Eric (author), Bhosale, Priya (author), Krishnan, Sunil (author), Das, Prajnan (author), Ho, Linus (author), Xiong, Henry (author), Abbruzzese, James (author), Evans, Douglas (author)
Format:	article
Published:	2007
Online Access:	http://hdl.handle.net/10725/2594 http://dx.doi.org/10.1200/JCO.2007.15.8642 http://jco.ascopubs.org/content/26/21/3487.short
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Similar Items